Evidence-first beauty intelligence for melanin-rich skin in Africa

Topic hub

Hyperpigmentation & PIH

Post-inflammatory hyperpigmentation is the highest-priority vertical: clinical evidence, search demand, and consumer pain language converge.

Understanding, preventing, and treating post-inflammatory hyperpigmentation (PIH) on melanin-rich skin, with every claim tied to fetched evidence.

Post-inflammatory hyperpigmentation (PIH) is the single most important concern for this platform's audience. A 2024 systematic review of 48 studies covering 1,356 skin-of-colour individuals found PIH disproportionately affects darker skin tones — with 78% of affected individuals female and a mean age of 29: exactly this audience.

The evidence on this hub is tiered. Every clinical statement traces to a source that was actually fetched, and consumer-experience content is labelled as such — never presented as clinical evidence.

What the evidence covers

Understanding PIH

PIH is the dark mark left behind after inflammation — acne, eczema, insect bites, or injury. In skin of colour it is often more distressing than the triggering condition itself: a 2022 clinical review notes acne lesions improve weeks before PIH resolves.

Why inflammation leaves dark marks

Inflammation stimulates melanocytes to overproduce melanin, which deposits in the epidermis and dermis. The darker the skin tone, the stronger this response tends to be.

Common triggers

Acne is the dominant trigger for this audience. Other documented triggers include eczema flares, pseudofolliculitis barbae, and cosmetic procedures performed without pigment-safe protocols (pseudofolliculitis barbae prevalence documented at snippet level only — flagged accordingly).

Skincare routines and barrier care

A fetched systematic review of 47 PIH studies (1,853 subjects) found SPF30+ broad-spectrum sunscreen recommended in almost every high-quality study, with topical retinoids, hydroxy acids, and broad-spectrum sunscreen carrying the greatest evidence support.

Sun protection

Sunscreen is the best-evidenced component of any PIH routine. Visible light also contributes to pigmentation in darker phototypes — see the sunscreen topic for the tinted-sunscreen evidence.

Ingredient explainers

See the ingredient library for ingredient-level evidence ratings. Ingredient evidence does not transfer to specific commercial products at different concentrations.

Product selection

Product listings are verified per market with provenance and check dates. A listing does not establish efficacy.

Myths and misleading claims

Misinformation module is under construction — the research checkpoint lists 10 myths but the record-level data is not yet in this repository. No myths are published until the underlying records are supplied.

When to seek professional care

Seek medical evaluation for: worsening melasma, PIH not responding after 3-6 months of consistent care, and any suspected skin cancer. Prescription treatments (tretinoin, hydroquinone 4%, oral tranexamic acid, azelaic acid 20%) require appropriate medical supervision and are never routine first-line recommendations.

Latest on Hyperpigmentation & PIH

Sources for this hub

When to see a clinician.Seek medical evaluation for worsening melasma, post-inflammatory hyperpigmentation that has not responded after 3–6 months of consistent care, and any suspected skin cancer. Prescription treatments — tretinoin, hydroquinone 4%, azelaic acid 20%, oral tranexamic acid — require appropriate medical supervision and are not routine first-line recommendations.

Get the brief

Hyperpigmentation & PIH — African Beauty Intelligence